CORREVIO PHARMA CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+1.06% | +2.41% |
| 2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
| 2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORREVIO PHARMA CORP. | Specialty & Advanced Pharmaceuticals | -.--% | +1.06% | - | - | - | 27.65M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- CORV Stock
- CORV Stock
- Charts Correvio Pharma Corp.
- Comparison Chart